Fisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares
** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39 ** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34 ** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption ** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co ** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55
Recent news on Fisher & Paykel Healthcare
See all newsNZ's Fisher & Paykel Healthcare slips, Morningstar says co overvalued
Morningstar says NZ's Fisher & Paykel Healthcare overvalued
Refile: BRIEF-Fisher & Paykel Healthcare Posts FY Net Income NZ$468.5 Mln
Brief: Fisher Paykel Healthcare Sees FY Operating Revenue To Be In Range Of NZ$2.45 Billion To NZ$2.57 Billion
New Zealand's Fisher & Paykel Healthcare rises on upbeat FY27 earnings forecast